ATTEND THE 2025 MEETING

Our annual meeting includes two days of scientific presentations as well as the business meeting for active members in the society

The annual meeting of the Neurosurgical Society of the Virginias takes place at one of the premiere resorts of Virginia or West Virginia each January. Any healthcare professional with an interest in the care of neurosurgical patients is welcome to attend and participate in the meeting.  The meeting typically includes a welcome reception followed by two days of category I CME scientific presentations.   One day is dedicated to clinical and scientific research performed by the neurosurgeons in training at one of the area’s residency programs. The second day is dedicated to presentations by the area’s private practice and academic neurosurgeons, as well other healthcare professionals and experts.  An honored guest, which is typically a neurosurgeon or health care leader with a national or international reputation, is invited and provides two additional presentations on their area of expertise.  All members of the Society are encouraged to attend the business meeting, which occurs separately from the scientific sessions and helps to set the agenda and goals for the Society moving forward.

Honored Guest Lecture

In January 2020, after an extensive national search, Dr. Kalkanis was named Executive Vice President of Henry Ford Health and the Chief Executive Officer of the Henry Ford Medical Group, with over 2,000 physicians and researchers, and Chief Academic Officer, with over 1,100 ACGME-approved residents and fellows across five acute care hospitals, based in southeast Michigan. In 2023 he was asked to take on the additional role of CEO of Henry Ford Hospital, the system’s flagship main campus hospital in Detroit, responsible for over $4.5B in clinical revenue annually. Before taking over as CEO, Dr. Kalkanis served as professor and chair of the Department of Neurosurgery, and co-director of the Neuroscience Institute at Henry Ford in Detroit, Michigan, where he was the founding Medical Director of the Henry Ford Cancer service line, one of the largest in the country, and oversaw the building of the new Brigitte Harris Cancer Pavilion at Henry Ford. Dr. Kalkanis and his team also spearheaded one of the country’s most comprehensive precision medicine and molecular tumor board programs for all cancer types.

In 2021, Dr. Kalkanis was also named the inaugural President of the newly formed Henry Ford Health-Michigan State University Health Sciences enterprise, while serving as the first regional dean of the Henry Ford campus of the MSU College of Human Medicine.

Dr. Kalkanis joined Henry Ford in 2004 after completing his neurosurgical training at Massachusetts General Hospital. He graduated with highest honors from Harvard University, where he was awarded the John Harvard Scholarship, and then Harvard Medical School, where he served as class marshal and received the Linnane Prize for highest academic achievement.

In 2009, Dr. Kalkanis led a multidisciplinary team of experts to publish the largest set of guidelines to date on the treatment pathways for metastatic brain tumors. Since then, he has chaired the guidelines efforts of the Joint Section on Tumors and was the founding chair of the Congress of Neurological Surgeons (CNS) Guidelines Committee, where he helped to spearhead ten separate clinical guidelines in multiple topics.

Dr. Kalkanis has served on the Executive Committee of the CNS, the largest neurosurgical association in the world, since 2009, and recently completed his term in 2021 as President of the CNS, one of the most visible neurosurgical leadership roles in the country. He also serves as Past-Chair for the Section on Tumors of the CNS and American Association of Neurological Surgeons, and he is a past president of the Michigan Association of Neurological Surgeons. In 2018, Dr. Kalkanis was chosen to receive one of the profession’s highest honors in being named Director of the American Board of Neurological Surgery, the accrediting and credentialing body for all neurosurgeons in the United States.

With the goal of refining future personalized medicine treatment protocols, and as the Mark Rosenblum Endowed Chair in Neurosurgery, Dr. Kalkanis runs a funded translational research laboratory investigating the molecular genetic differences between short-and long-term glioma survivors. Specializing in brain tumor surgery, he has been involved in numerous clinical trials for brain tumors and has authored over 200 peer reviewed publications and has been invited on over 60 occasions as a visiting professor around the world.

Steve and his wife Laurel especially enjoy traveling with, and cheering on, their three children, Nicholas, Connor and Grace, in multiple athletic and musical activities.

THE NEUROSURGICAL SOCIETY OF THE VIRGINIAS

Copyright © 2018 The Neurosurgical Society of the Virginias - All Rights Reserved.